Regulatory Briefs: FDA Plans To Study Explanted Hips, Announces Upcoming Meetings
This article was originally published in The Gray Sheet
Executive Summary
FDA is seeking applicants to help run an explant analysis study on hip implants. The agency plans a workshop on incorporating patient preference into CDRH regulatory decisions and a meeting with health professional organizations. More regulatory news.